Fungal Biofilm: An Overview of the Latest Nano-Strategies
Antibiotics · 17.07.2025 · 14 (7) · 718
DOI: 10.3390/antibiotics14070718 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 17.07.2025. Verfasst von Andrea Giammarino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, 00100 Rome, Italy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: There is an increasing incidence of fungal infections in conjunction with the rise in resistance to medical treatment. Antimicrobial resistance is frequently associated with virulence factors such as adherence and the capacity of biofilm formation, which facilitates the evasion of the host immune response and resistance to drug action. Novel therapeutic strategies have been developed to overcome antimicrobial resistance, including the use of different type of nanomaterials: metallic (Au, Ag, Fe3O4 and ZnO), organic (e.g., chitosan, liposomes and lactic acid) or carbon-based (e.g., quantum dots, nanotubes and graphene) materials. The objective of this study was to evaluate the action of nanoparticles of different synthesis and with different coatings on fungi of medical interest.
Methods
Literature research was conducted using PubMed and Google Scholar databases, and the following terms were employed in articles published up to June 2025: ‘nanoparticles’ in combination with ‘fungal biofilm’, ‘Candida biofilm’, ‘Aspergillus biofilm’, ‘Cryptococcus biofilm’, ‘Fusarium biofilm’ and ‘dermatophytes biofilm’.
Results
The utilization of nanoparticles was found to exert a substantial impact on the reduction in fungal biofilm, despite the presence of substantial variability in minimum inhibitory concentration (MIC) values attributable to variations in nanoparticle type and the presence of capping agents. It was observed that the MIC values were lower for metallic nanoparticles, particularly silver, and for those synthesized with polylactic acid compared to the others.
Conclusions
Despite the limited availability of data concerning the stability and biocompatibility of nanoparticles employed in the treatment of fungal biofilms, it can be posited that these results constitute a significant initial step.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, 00100 Rome, Italy.
- Department of Environmental Biology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
ORCID-Profile: Andrea Giammarino, Laura Verdolini, Giovanna Simonetti, Letizia Angiolella
Zitieren
APA
Giammarino, A., Verdolini, L., Simonetti, G., & Angiolella, L. (2025). Fungal Biofilm: An Overview of the Latest Nano-Strategies. Antibiotics, 14(7), 718. https://doi.org/10.3390/antibiotics14070718
Vancouver
Giammarino A, Verdolini L, Simonetti G, Angiolella L. Fungal Biofilm: An Overview of the Latest Nano-Strategies. Antibiotics. 2025;14(7):718. doi:10.3390/antibiotics14070718
BibTeX
@article{Giammarino2025,
author = {Giammarino, Andrea and Verdolini, Laura and Simonetti, Giovanna and Angiolella, Letizia},
title = {Fungal Biofilm: An Overview of the Latest Nano-Strategies},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {7},
pages = {718},
doi = {10.3390/antibiotics14070718}
}
EUVIMED